p53 splice acceptor site mutation and increased HsRAD51 protein expression in Bloom's syndrome GM1492 fibroblasts

被引:12
作者
Magnusson, KP
Sandström, M
Ståhlberg, M
Larsson, M
Flygare, J
Hellgren, D
Wiman, KG
Ljungquist, S
机构
[1] Karolinska Inst, Natl Inst Environm Med, S-17177 Stockholm, Sweden
[2] Karolinska Inst, MTC, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden
[3] Dept Biosci, Environm Med Unit, S-14157 Huddinge, Sweden
关键词
alternative splicing; exon deletion; promoter; RecA-like activity; transcription;
D O I
10.1016/S0378-1119(00)00068-8
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
SGM1492 human diploid skin fibroblasts derived from a patient with Bloom's syndrome (BS), lack detectable p53 mRNA and protein as shown by Northern and Western blotting, and express an increased RecA-like activity. Here we demonstrate that the p53 gene is grossly intact in GM1492 cells according to Southern blotting. DNA sequencing did not reveal any mutations in the promoter region of p53. A highly sensitive RT-PCR produced a p53 cDNA fragment that was shorter than expected. DNA sequence analysis of p53 cDNA showed that exon 6 was missing, explaining the shorter PCR product. Furthermore, sequencing of genomic DNA revealed a base substitution at the nucleotide preceding the AG splice acceptor site of intron 5. The omission of exon 6 creates a frameshift at the junction of exons 5 and 7, and a premature stop codon in exon 7. The aberrant transcript is predicted to encode a truncated p53 protein containing 189 amino acid residues. Moreover, Western blotting demonstrated elevated HsRAD51 protein levels in GM1492 cells. The lack of sufficient levels of wild-type p53 and increased levels of HsRadS1 protein may contribute to the elevated RecA-like activity in the GM1492 fibroblasts. (C) 2000 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:247 / 254
页数:8
相关论文
共 34 条
[1]   PROGRESSIVE B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA FREQUENTLY EXHIBITS ABERRANT P53 EXPRESSION [J].
AGUILARSANTELISES, M ;
MAGNUSSON, KP ;
WIMAN, KG ;
MELLSTEDT, H ;
JONDAL, M .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (04) :474-479
[2]   ALTERATIONS IN THE P53 GENE AND THE CLONAL EVOLUTION OF THE BLAST CRISIS OF CHRONIC MYELOCYTIC-LEUKEMIA [J].
AHUJA, H ;
BARELI, M ;
ADVANI, SH ;
BENCHIMOL, S ;
CLINE, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) :6783-6787
[3]  
ALBOR A, 1994, CANCER RES, V54, P4502
[4]   A novel germ line p53 mutation in intron 6 in diverse childhood malignancies [J].
Avigad, S ;
Barel, D ;
Blau, O ;
Malka, A ;
Zoldan, M ;
Mor, C ;
Fogel, M ;
Cohen, IJ ;
Stark, B ;
Goshen, Y ;
Stein, J ;
Zaizov, R .
ONCOGENE, 1997, 14 (13) :1541-1545
[5]   P53 BINDS SINGLE-STRANDED-DNA ENDS THROUGH THE C-TERMINAL DOMAIN AND INTERNAL DNA SEGMENTS VIA THE MIDDLE DOMAIN [J].
BAKALKIN, G ;
SELIVANOVA, G ;
YAKOVLEVA, T ;
KISELEVA, E ;
KASHUBA, E ;
MAGNUSSON, KP ;
SZEKELY, L ;
KLEIN, G ;
TERENIUS, L ;
WIMAN, KG .
NUCLEIC ACIDS RESEARCH, 1995, 23 (03) :362-369
[6]   Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein [J].
Bertrand, P ;
Rouillard, D ;
Boulet, A ;
Levalois, C ;
Soussi, T ;
Lopez, BS .
ONCOGENE, 1997, 14 (09) :1117-1122
[7]   Interaction of p53 with the human Rad51 protein [J].
Buchhop, S ;
Gibson, MK ;
Wang, XW ;
Wagner, P ;
Sturzbecher, HW ;
Harris, CC .
NUCLEIC ACIDS RESEARCH, 1997, 25 (19) :3868-3874
[8]   Databases and software for the analysis of mutations in the human p53 gene, the human hprt gene and the lacZ gene in transgenic rodents [J].
Cariello, NF ;
Douglas, GR ;
Soussi, T .
NUCLEIC ACIDS RESEARCH, 1996, 24 (01) :119-120
[9]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[10]  
FELIX CA, 1993, ONCOGENE, V8, P1203